April 2020 COVID-19: KEY CONSIDERATIONS FOR GASTROENTEROLOGISTS Featuring: Stephen B. Hanauer, MD and Scott A. Strong, MD
Episode SummaryIn this episode of the Better Edge podcast, Stephen B. Hanauer, MD, and Scott A. Strong, MD, discuss key considerations for gastroenterologists in the context of coronavirus disease (COVID-19). Topics include gastrointestinal manifestations, risks and treatment for patients with inflammatory bowel disease (IBD) or other conditions who may be taking immunosuppression drugs, as well as potential fecal-oral transmission and how Northwestern Medicine Gastroenterology and GI Surgery are optimizing telehealth during this pandemic.
|
Stephen B. Hanauer, MD Clifford Joseph Barborka Professor and professor of medicine in the Division of Gastroenterology and Hepatology.
Stephen A. Strong, MD vice chair for clinical affairs in the Department of Surgery, chief of gastrointestinal surgery in the Department of Surgery and James R. Hines, MD, Professor of Surgery (Gastrointestinal).
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|